J Bras Patol Med Lab • v. 48 • n. 4 • p. 281-285 • agosto 2012 reLato de caso case report Extramedullary plasmacytoma comprises 3%-5% of all plasma cell neoplasms, and approximately 80% of the cases occur in the upper respiratory tract. Primary thyroid plasmacytomas (PTP) are rare tumors. The authors report a case of PTP in a male patient with dyspnea and dysphagia. Physical examination and computerized tomography (CT) scan revealed a solid tumor affecting the thyroid gland, measuring 12 cm in its greatest dimension. Surgical biopsy was performed. Microscopy revealed a hypercellular malignant neoplasm composed of round plasmacytoid cells arranged in solid nests, which showed a positive immunoexpression for CD138, epithelial membrane antigen (AME), kappa light chains and multiple myeloma oncogene 1 (MUM1). 
Introduction
The majority of thyroid neoplasms are primary and shows epithelial differentiation. Papillary carcinoma of the thyroid is the most common malignant tumor in the gland in countries having iodine-sufficient or iodine-excess diets, affecting more frequently women between the third and fifth decades. Primary lymphoid tumors arising in the thyroid are seen more commonly on elderly females, being diffuse large B-cell lymphoma the most common histological type (1, 7, 12) . Plasma cell myeloma is more frequently seen as a bone marrow-based, multifocal neoplasm characterized by a serum monoclonal protein, skeletal osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anaemia. Extraosseous (extramedullary) plasmacytomas constitute 3%-5% of all plasma cell neoplasms. Patients are typically adults (median age 55) with a 2:1 male:female ratio, and approximately 80% of these lesions occur in the upper respiratory tract. Plasmacytoma affecting the thyroid parenchyma are more commonly seen as a component of widespread myeloma, presenting as a palpable nodule in about 2.6% in this group of patients. Thyroid primary plasmacytoma is a very rare neoplasm (3, 6, 9, 11) .
Herein, the authors report a case of primary thyroid plasmacytoma with no clinical evidence of systemic disease, and review clinical features, pathological findings and diagnostic criteria of this tumor.
Case report
Male patient, 56 years, caucasian, came to the ambulatorial service reporting dyspnea and dysphagia beginning three months. He also reported the presence of a nodular lesion in the cervical region with progressive growth. Physical examination showed the presence of a solid tumor with indistinct borders in the anterior cervical region, associated with enlarged lymph nodes. The patient had a history of hypothyroidism with levothyroxine use. The computed tomography (CT) scan revealed the presence of a neoplastic process affecting predominantly the isthmus and right lobe of the thyroid gland, which measured 12 cm in greatest dimension and determined deviation of the trachea to the left. At fibrobroncoscopic examination, an accentuated stenosis of the tracheal lumen by an extrinsic process was found, without involvement of the mucosa. The neoplastic process and the cervical lymph nodes underwent fine needle aspiration. The Pap test identified the presence of some atypical polyhedral cells consistent with hematopoietic malignancy in the thyroid smears, and numerous lymphocytes in a hyperplastic pattern in the lymph nodes smears. Because of progressive dyspnea, the patient underwent tracheostomy and biopsy of the lesion. At microscopic, a hypercellular malignant neoplasm constituted by round or plasmacytoid cells arranged in solid nests and/or in a diffuse pattern was found (Figure 1) , which exhibited high mitotic index ( Figure 2 ) and with foci of necrosis too. The immunohistochemistry of the lesion showed positive expression for the antibodies CD138 (Figure 3) , epithelial membrane antigen (EMA), kappa light chains of immunoglobulins (Figure 4 ), MUM1 and CD56 (weak and focal) and negative expression for CD20 antibody, lambda light chains of immunoglobulins and pancytokeratin (AE1/AE3). The laboratory data are described in Table. Conventional radiological study and the scintigraphy of the skull, chest, spine and upper and lower limb did not identified any lytic or blastic bone lesion. The diagnosis of plasmacytoma of the thyroid gland was then established. Although the specific treatment regimen established, which included radiation therapy, patient past way from respiratory failure.
Discussion
Multiple myeloma is a tumor of hematopoietic derivation, and it is the most common primary malignant neoplasm of bone. The disease spans a spectrum from localized, indolent lesion, to aggressive, disseminated forms with plasma cell infiltration of various organs. Solitary plasmacytoma comprises a minor percentual of the plasma cell neoplasms, and it is characterized by a clonal proliferation of plasma cells that are cytologically and immunophenotypically identical to those of multiple myeloma, but it arises as a single localized osseous lesion. Solitary plasmacytoma of bone affects more frequently the vertebrae, ribs, skull, pelvis, femur, clavicle, and scapula (2, 6, 8, 9) . Extraosseous (extramedullary) plasmacytoma are uncommon plasma cell neoplasms, that arise typically in adults with a median age of 55 years, and approximately 80% of the cases occur in the upper respiratory tract including the oropharynx, sinuses and larynx. They may occur also in the gastrointestinal tract, urinary bladder, central nervous system, breast, testis, parotid gland, lymph nodes, and skin. Thyroid primary plasmacytoma are extremely rare tumors. By definition, there is no evidence of plasma cell myeloma on bone marrow examination or by radiography. 15%-20% of patients may have a monoclonal gammopathy. There is no evidence of anaemia, hypercalcemia, or renal insufficiency, and Bence-Jones protein is occasionally found in the urine (2, 5, 6, 8, 9, 15) .
On gross evaluation, the thyroid gland compromised by a primary plasmacytoma is enlarged in weight and size. On cut surface, in most cases, the thyroid parenchyma shows a soft gelatinous, fish-flesh, ill-defined solid nodule, or a diffuse, soft gray process. The size of the tumor ranges from a few centimeters in diameter to large tumoral masses, which can involve the extrathyroidal tissues too. Occasionally, the lesion shows areas of necrosis and hemorrhage. On histopathological evaluation, the neoplastic plasma cells vary from mature forms to immature, anaplastic cells. In the mature form, the plasma cells are usually oval, with a round eccentric nucleus with a "spoke wheel" chromatin without nucleoli, with abundant basophilic cytoplasm and a marked perinuclear hof. In immature forms, the cells have dispersed nuclear chromatin, a high nuclear/cytoplasm ratio, and prominent nucleoli. Multinucleated, pleomorphic cells can be found. The cytoplasm of the neoplastic plasma cells contains abundant endoplasmic reticulum, which may contain retained, condensed or crystallized cytoplasmic immunoglubulins. On immunohistochemistry evaluation, the neoplastic plasma cells shows positivity for monotypic cytoplasmic immunoglobulin (more commonly immunoglobulin class G [IgG ]), CD38, CD56/58, CD138, kappa/ lambda light chain immunoglubulins, and EMA. Most cases of extraosseous plasmacytoma lack immunoexpression for CD19, CD20, keratin, and chromogranin A. The differential diagnosis includes B-cell lymphomas, MALT lymphomas, medullary carcinoma of the thyroid, and metastatic neoplasms like malignant melanoma (3-5, 9-11, 13, 14, 16) . The treatment for extraosseous plasmacytoma typically consists of radiation therapy. Regional recurrences develop in approximately 25% of patients, with the development of typical plasma cell myeloma in about 15% of the cases (2, 5, 9, 16) . Herein, the authors described the clinical and pathological findings of a primary plasmacytoma of the thyroid gland. Since the management of extramedullary plasmacytoma is markedly different from the primary thyroid carcinoma, it is fundamental its initial recognition by fine-needle aspiration and clinical analysis of laboratory and imaging data.
